Scholarlink

<p>The antitumor activity and the underlying mechanism of six novel curcumin derivatives (<b>F1–F6</b>) were evaluated in lung cancer cells. <b>F5</b> was found to be the most potent derivative (IC<sub>50</sub> = 13.67 μM) compared to curcumin (IC<sub>50</sub> = 40.93 μM), with significant differences via MTT assay. A series of pharmacological experiments, including clone formation, wound healing, and transwell assay, reveal that <b>F5</b> can inhibit lung cell proliferation and migration. Western blot and molecular docking studies demonstrate that the potential mechanism may relate to the regulation of the AKT/ERK/MMP9 signaling pathway. Therefore, curcumin derivative <b>F5</b> can potentially be used for treating lung cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Discovery of Novel Curcumin Derivatives as Potential Anti-Lung Cancer Agents by Inhibiting Cell Proliferation and Migration

  • 期刊论文

  • 发表日期：

    2025年3月25日

查看全文
  • Weiya Cao,
  • Pan Yu,
  • Qiaoping Wu,
  • Na Che,
  • Siyuan Liu,
  • Nan Yin,
  • Shuhui Feng

摘要

The antitumor activity and the underlying mechanism of six novel curcumin derivatives (F1–F6) were evaluated in lung cancer cells. F5 was found to be the most potent derivative (IC50 = 13.67 μM) compared to curcumin (IC50 = 40.93 μM), with significant differences via MTT assay. A series of pharmacological experiments, including clone formation, wound healing, and transwell assay, reveal that F5 can inhibit lung cell proliferation and migration. Western blot and molecular docking studies demonstrate that the potential mechanism may relate to the regulation of the AKT/ERK/MMP9 signaling pathway. Therefore, curcumin derivative F5 can potentially be used for treating lung cancer.